KLTO (Klotho Neurosciences) Price-to-Operating-Cash-Flow : (As of May. 27, 2025)

View and export this data going back to 2024. Start your Free Trial

What is Klotho Neurosciences Price-to-Operating-Cash-Flow?

As of today (2025-05-27), Klotho Neurosciences's share price is $0.206. Klotho Neurosciences's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2025 was $-0.21. Hence, Klotho Neurosciences's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Klotho Neurosciences's Price-to-Operating-Cash-Flow or its related term are showing as below:

KLTO's Price-to-Operating-Cash-Flow is not ranked ^*
in the Biotechnology industry.
Industry Median: 24.23
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Klotho Neurosciences's Cash Flow from Operations per share for the three months ended in Mar. 2025 was $-0.06. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2025 was $-0.21.

Klotho Neurosciences Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Klotho Neurosciences's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Klotho Neurosciences Price-to-Operating-Cash-Flow Chart

Klotho Neurosciences Annual Data

Trend

Dec21

Dec22

Dec23

Dec24

Price-to-Operating-Cash-Flow

Klotho Neurosciences Quarterly Data
	Dec21	Jun22	Dec22	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial						-	-	-	-	-

Competitive Comparison of Klotho Neurosciences's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, Klotho Neurosciences's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Klotho Neurosciences's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Klotho Neurosciences's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Klotho Neurosciences's Price-to-Operating-Cash-Flow falls into.

Save Embed

;

Save Embed

;

Klotho Neurosciences Price-to-Operating-Cash-Flow Calculation

Klotho Neurosciences's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	0.206	/	-0.213
	=

Klotho Neurosciences's Share Price of today is $0.206.
Klotho Neurosciences's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.21.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Klotho Neurosciences Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Klotho Neurosciences's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Klotho Neurosciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Klotho Neurosciences Inc (NAS:KLTO) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

N/A

Address

13576 Walnut Street, Suite A, Omaha, NE, USA, 68144

Website

https://www.klothoneuro.com

Klotho Neurosciences Inc is in the development of essential medicines for the treatment of chronic diseases: Cancer, Cardiovascular, and Neurodegenerative disorders. The Company currently has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and a proprietary, patented gene therapy platform which uses a gene therapy approach to introduce a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases. Company pipeline includes KLTO 101, KLTO 202, KLTO 301.